HOME >> BIOLOGY >> NEWS
UCSF researchers identify regulator of critical brain messenger, hinting at therapy

In the dynamic world of the central nervous system, the neurotransmitter glutamate is a key player, ceaselessly transmitting critical instructions between nerve cells. Now, UCSF researchers have identified the protein that transports the chemical signal to its launch site in nerve cells, offering a possible new target for treating such diseases as Alzheimer's disease.

The discovery opens a vast field of potential therapy, for while glutamate carries out such fundamental processes as sensory perception, learning and memory, changes in its role contribute to many brain diseases. The release of too much glutamate causes excessive excitation in the nervous system that leads to seizures, contributes to injury after stroke, the perception of pain and even the destruction of nerve cells associated with neurodegeneratives diseases, including Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (Lou Gehrig's disease). A drug that blocked the glutamate transporter from loading glutamate, thus reducing the release of glutamate, could treat these illnesses.

Alternatively, increasing the amount of glutamate released from certain nerve cells could improve learning, memory skills and overall cognitive function. In this case, therapy might simply involve taking a drug that increases the expression of the gene that produces the protein transporter. The resulting increased expression of the protein would enable nerve cells to store and release more glutamate.

"We've never had a drug that inhibits the release of glutamate, but we presume it would have dramatic effects," says the senior author of the study, Robert H. Edwards, MD, UCSF professor of neurology and physiology. Glutamate, like all neurotransmitters, is a chemical message released by one nerve cell and targeted at another. Thousands of glutamate molecules are released from a single cell, prompting a response in a neighboring cell, which prompts a response in yet another cell. The milli
'"/>

Contact: Jennifer O'Brien
jobrien@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
10-Aug-2000


Page: 1 2 3 4 5

Related biology news :

1. Belgian researchers explore revolutionary approach to angiogenesis
2. Award winning researchers reveal potential new role for Glivec
3. $7.5 Million grant to Yale researchers for role of viruses in cancer
4. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
5. Joslin researchers clarify mechanisms for beta-cell formation
6. Virginia Tech researchers to release findings on Smith River Project
7. Molecular motor myosin VI moves hand over hand, researchers say
8. ASU researchers demonstrate new technique that improves the power of atomic force micrscopy
9. Emory researchers map structure of anti-cancer molecule
10. Leukemia stem cells identified by Stanford researchers
11. EURYI Award given for the first time to 25 young European researchers

Post Your Comments:
(Date:5/16/2013)... have used ancient shorelines to predict the stability of today,s ... high shoreline from three million years ago, for example ... thought to be evidence of a high sea level due ... led many scientists to think that if the world,s largest ... just the same in our modern, progressively warming world. ...
(Date:5/16/2013)... MIT may someday eliminate the need for patients ... blood-sugar levels and inject themselves with insulin. , ... in the body and respond by secreting the ... of pancreatic islet cells, which are destroyed in ... of system could ensure that blood-sugar levels remain ...
(Date:5/16/2013)... May 16, 2013 The relationship between the ... has not been clear. Schizophrenia is commonly associated ... There are clues that reduced IQ may be ... example, reduced cognitive ability may precede the onset ... present in healthy relatives of people diagnosed with ...
Breaking Biology News(10 mins):World's biggest ice sheets likely more stable than previously believed 2Nanotechnology could help fight diabetes 2Nanotechnology could help fight diabetes 3Genetic risk for schizophrenia is connected to reduced IQ 2
(Date:5/17/2013)... JOSE, Calif. , May 17, 2013 /PRNewswire-iReach/ ... agreement has been reached with Switzerland ... portfolio of anti-infective human monoclonal antibody (mAb) products, ... anti-infective human mAb products for treatment of infections ... of Staphylococcus aureus , Pseudomonas aeruginosa ...
(Date:5/17/2013)... The paradigm of ‘one drug, one target’ ... help predict the adverse and therapeutic effects of a ... Computational Biology at the Genomics Laboratory, Covance, will discuss ... genomics when used as part of the QC process. ... sets to identify key clinical targets even in complex ...
(Date:5/17/2013)... IAC Industries wants to share with you the success ... set up and furnish a research lab knowing that the ... year’s time. How does a company make choices in lab ... is efficient and cost-effective? , The solution was the ... planners at DisperSol determined that the concept of modular lab ...
(Date:5/16/2013)... ISPE announced today that ... the newly created position of Vice President of ... be responsible for stimulating ISPE’s revenue growth by ... Society’s Member-led and staff-driven business model, initiating integrated ... membership and product marketing. , “Barbara joins ISPE ...
Breaking Biology Technology:Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 3New Downloadable Success Story: “How To Outfit a Dynamic Lab in Flux” 2ISPE Names Barbara A. Myers, CAE, as Vice President of Professional Development 2
Cached News: